scholarly article | Q13442814 |
P356 | DOI | 10.1159/000058533 |
P8608 | Fatcat ID | release_mnwmpwsgbzg3hmskbwtnqn6ile |
P698 | PubMed publication ID | 11408805 |
P2093 | author name string | Ishii S | |
Wada T | |||
Sawada N | |||
Yamawaki S | |||
Kokai Y | |||
Akatsuka T | |||
P433 | issue | 4 | |
P304 | page(s) | 361-366 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Oncology | Q2016300 |
P1476 | title | Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma | |
P478 | volume | 60 |
Q80510573 | Biology and therapy of malignant solid tumors in childhood |
Q33929072 | Biomarkers in Osteosarcoma |
Q35894540 | Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy |
Q54271327 | Comments on Liu Yet al. "Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies". |
Q54347202 | Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies |
Q77838982 | ErbB2 expression is correlated with increased survival of patients with osteosarcoma |
Q47688406 | Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma |
Q58556369 | HER-2 Immunohistochemical Expression in Bone Sarcomas: A New Hope for Osteosarcoma Patients |
Q36046928 | HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies |
Q34887225 | HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. |
Q38219839 | HER-2 involvement in osteosarcoma |
Q37389600 | Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies. |
Q54361340 | Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients |
Q42444949 | Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma |
Q40661098 | Question about Liu Y et al. entitled "Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies". |
Q36803657 | Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro |
Q34179495 | Strategies for the targeted delivery of therapeutics for osteosarcoma |
Search more.